In Iran, the therapeutic products offered by ASAlaser are experiencing notable success, proof of which can be found in the intense promotional activities carried out by our local partner, Artiman, and their participation in important industry conventions. The most recent of these was the Annual Iranian Congress of Physical Medicine, Rehabilitation & Electrodiagnosis from 3 to 5 February at the Olympic Hotel in Tehran, where our local distributor participated and promoted MLS® and Hilterapia®. ASAlaser’s therapeutic devices caught the interest of numerous visitors to the stand hosted by Artiman, which dedicated a large space to the Hiro 3.0 system and to the MLS® M6 and Mphi Trolley units. “The continuous visits to see our therapeutic devices by clients and potential clients, with whom there were various moments of interaction and comparison,” said Roberto Terruzzi, Senior Area Manager, “is testimony to how Artiman is recognized as an important player in the sector”.
Along with the active participation in the conference in Tehran, Ali Madani, the owner of Artiman, planned an event within the event: a workshop dedicated to MLS® and Hilterapia® on Thursday, 4 February. The training session, hosted by Lucio Zaghetto, the CEO of ASAlaser, involved 30 % of all participants in the congress interested in the topic. “The in-depth questions asked by those present were so numerous that the discussion continued at Artiman’s headquarters”, added Roberto Terruzzi.
Participation in the congress was also an opportunity to carry out a training session for our local distributor’s team on the specific details of MLS® and Hilterapia®: among the eight participants was Dr. Ali Panahi, Clinical Trainer as well as user of SH1 and Mphi at his private clinic in Tehran.
“The trip to Iran”, remarked Lucio Zaghetto, “met all of our pre-established goals, further confirming the validity, innovation and scientific basis of our therapeutic devices in the Iranian market”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.